{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:44:13Z","timestamp":1792107853344,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["2018ZSLC26"],"award-info":[{"award-number":["2018ZSLC26"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijrobp.2024.03.030","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T15:41:06Z","timestamp":1713195666000},"page":"422-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial"],"prefix":"10.1016","volume":"120","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaonan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisuo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-an","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaochong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.03.030_bib0001","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2011.02.014","article-title":"Dose escalation for non-small cell lung cancer: Analysis and modelling of published literature","volume":"99","author":"Partridge","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0004","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2017.04.004","article-title":"Radiation treatment time and overall survival in locally advanced non-small cell lung cancer","volume":"98","author":"McMillan","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0005","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1200\/JCO.2017.74.0720","article-title":"Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer","volume":"36","author":"Liao","year":"2018","journal-title":"J Clinl Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0006","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: Durvalumab after chemoradiotherapy in stage \u2162 non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0007","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2019.08.034","article-title":"Patterns of disease progression with durvalumab in stage \u2162 non-small cell lung cancer (PACIFIC)","volume":"105","author":"Schmid","year":"2019","journal-title":"Int J Radiatn Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0008","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0009","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2007.03.010","article-title":"Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation","volume":"68","author":"Bese","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0010","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/jamaoncol.2021.3180","article-title":"Radiation dose and fractionation in locally advanced lung cancer: A simple question with a complicated Answer","volume":"7","author":"Khandekar","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2010.09.004","article-title":"Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group","volume":"82","author":"Machtay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0012","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/153303460600500503","article-title":"Clinical implementation of adaptive helical tomotherapy: A unique approach to image-guided intensity modulated radiotherapy","volume":"5","author":"Welsh","year":"2006","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0013","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ijrobp.2006.02.038","article-title":"Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: A comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy","volume":"65","author":"Sheng","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0014","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/153303461000900308","article-title":"Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: Dosimetric analysis incorporating quality assurance guidelines from RTOG 0225","volume":"9","author":"Chen","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0015","article-title":"Outcomes of hypofractional tomotherapy in patients with stage \u2162 nonsmall cell lung cancer who are not eligible for surgery or concurrent chemoradiation","volume":"2020","author":"Li","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0016","doi-asserted-by":"crossref","first-page":"862","DOI":"10.21037\/jtd.2016.03.46","article-title":"Feasibility and efficacy of helical intensity-modulated radiotherapy for stage \u2162 non-small cell lung cancer in comparison with conventionally fractionated 3D-CRT","volume":"8","author":"He","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0017","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.06.075","article-title":"Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable stage \u2162 non-small cell lung cancer using helical tomotherapy","volume":"77","author":"Bral","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2721261","article-title":"Outcomes of image-guided moderately hypofractionated radiotherapy for stage \u2162 non-small-cell lung cancer","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0019","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Euro J Cancer (Oxford, England: 1990)"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0020","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0021","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/JTO.0b013e3182429682","article-title":"Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma","volume":"7","author":"Machtay","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0022","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/annonc\/mdx009","article-title":"Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage \u2162 non-small cell lung cancer: A multicenter randomized phase \u2162 trial","volume":"28","author":"Liang","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0023","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am J Respiry Crit Care Med"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0024","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/cncr.34201","article-title":"Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive\/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve","volume":"128","author":"Eze","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.radonc.2013.07.014","article-title":"Accelerated hypo-fractionated radiotherapy for non-small cell lung cancer: Results from 4 UK centres","volume":"109","author":"Din","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0026","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cllc.2014.08.002","article-title":"Radical-intent hypofractionated radiotherapy for locally advanced non-small-cell lung cancer: A systematic review of the literature","volume":"16","author":"Kaster","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0027","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ijrobp.2020.03.038","article-title":"Survival and toxicity of hypofractionated intensity modulated radiation therapy in 4 Gy fractions for unresectable stage \u2162 non-small cell lung cancer","volume":"107","author":"Kong","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijrobp.2018.01.046","article-title":"Phase 1 study of accelerated hypofractionated radiation therapy with concurrent chemotherapy for stage \u2162 non-small cell lung cancer: CALGB 31102 (Alliance)","volume":"101","author":"Urbanic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0029","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jamaoncol.2021.3186","article-title":"Accelerated hypofractionated image-guided versus conventional radiotherapy for patients with stage II\/\u2162 non-small cell lung cancer and poor performance status: A randomized clinical trial","volume":"7","author":"Iyengar","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0030","first-page":"532","article-title":"Improving outcomes in NSCLC: Optimum dose fractionation in radical radiotherapy matters","volume":"17","author":"Brada","year":"2022","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0031","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: The dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0032","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.8513","article-title":"Safety results of NRG-LU004: Phase I trial of accelerated or conventionally fractionated radiotherapy combined with durvalumab in PD-L1\u2013high locally advanced non-small cell lung cancer","volume":"40","author":"Lin","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0033","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) for non-small cell lung cancer V.7. Accessed May 8, 2024. https:\/\/www.nccn.org."},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-019-1287-z","article-title":"Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage \u2162 NSCLC","volume":"14","author":"Zhao","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0036","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0360-3016(03)00499-1","article-title":"Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT)","volume":"57","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0037","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0167-8140(03)00165-8","article-title":"The effect of fraction time in intensity modulated radiotherapy: Theoretical and experimental evaluation of an optimisation problem","volume":"68","author":"Mu","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0038","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1053\/j.seminoncol.2005.03.004","article-title":"Pilot study of accelerated radiotherapy with concurrent chemotherapy for stage \u2162 non-small cell lung cancer","volume":"32","author":"Machtay","year":"2005","journal-title":"Sem Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0039","first-page":"201","article-title":"Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy\/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage \u2162 non-small-cell lung cancer: A phase I trial","volume":"8","author":"Lin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.radonc.2020.04.033","article-title":"Accelerated hypofractionated radiotherapy with concurrent full dose chemotherapy for locally advanced non-small cell lung cancer: A phase I\/II study","volume":"148","author":"Glinski","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0041","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13014-017-0905-x","article-title":"Normal lung sparing Tomotherapy technique in stage \u2162 lung cancer","volume":"12","author":"Hong","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0042","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41598-021-04601-0","article-title":"Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer","volume":"12","author":"Tatsuno","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0043","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150409","article-title":"Evolution of radiation techniques in the treatment of mediastinal lymphoma: From 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): A single-centre experience and review of the literature","volume":"89","author":"Besson","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2024.03.030_bib0044","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/0971-6203.170792","article-title":"Dosimetric comparison of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and helical tomotherapy for lung stereotactic body radiotherapy","volume":"40","author":"Kinhikar","year":"2015","journal-title":"J Medl Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624004504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624004504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T10:22:20Z","timestamp":1738146140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624004504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0360301624004504"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.03.030","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}